Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Amyloidosis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Amyloidosis Therapeuticsmarket, defines the market attractiveness level of Amyloidosis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Amyloidosis Therapeutics industry, describes the types of Amyloidosis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Amyloidosis Therapeutics market and the development prospects and opportunities of Amyloidosis Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Amyloidosis Therapeutics market in Chapter 13.
By Player:
Isis Pharmaceuticals, Inc
ProteoTech, Inc
Celgene Corporation
Onyx Pharmaceuticals, Inc
Alnylam Pharmaceuticals, Inc
GlaxoSmithKline Plc
Pfizer Inc
Arcturus Therapeutics, Inc
Bsim2
Bellus Health Inc
Prothena Corporation Plc
SOM Innovation Biotech SL
Millennium Pharmaceuticals, Inc
By Type:
AG-10
ALN-ANG
ALN-TTRsc02
CAEL-101
canakinumab
Others
By End-User:
AL amyloidosis
AA amyloidoses
ATTR amyloidoses
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Amyloidosis Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Amyloidosis Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Amyloidosis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Amyloidosis Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Amyloidosis Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Amyloidosis Therapeutics Consumption (2017-2022)
-
7.2 United States Amyloidosis Therapeutics Consumption (2017-2022)
-
7.3 Europe Amyloidosis Therapeutics Consumption (2017-2022)
-
7.4 China Amyloidosis Therapeutics Consumption (2017-2022)
-
7.5 Japan Amyloidosis Therapeutics Consumption (2017-2022)
-
7.6 India Amyloidosis Therapeutics Consumption (2017-2022)
-
7.7 South Korea Amyloidosis Therapeutics Consumption (2017-2022)
8 Region and Country-wise Amyloidosis Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Amyloidosis Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Amyloidosis Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Amyloidosis Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Amyloidosis Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Amyloidosis Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Amyloidosis Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Amyloidosis Therapeutics Consumption Forecast (2022-2028)
9 Global Amyloidosis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Amyloidosis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AG-10 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ALN-ANG Consumption and Growth Rate (2017-2022)
-
9.1.3 Global ALN-TTRsc02 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CAEL-101 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global canakinumab Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Amyloidosis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global AL amyloidosis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global AA amyloidoses Consumption and Growth Rate (2017-2022)
-
9.2.3 Global ATTR amyloidoses Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Amyloidosis Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Amyloidosis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AG-10 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global ALN-ANG Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global ALN-TTRsc02 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CAEL-101 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global canakinumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Amyloidosis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global AL amyloidosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global AA amyloidoses Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global ATTR amyloidoses Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Amyloidosis Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Amyloidosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Amyloidosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Amyloidosis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Amyloidosis Therapeutics Market Competitive Analysis
-
14.1 Isis Pharmaceuticals, Inc
-
14.1.1 Isis Pharmaceuticals, Inc Company Details
-
14.1.2 Isis Pharmaceuticals, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Isis Pharmaceuticals, Inc Amyloidosis Therapeutics Product and Service
-
14.2 ProteoTech, Inc
-
14.2.1 ProteoTech, Inc Company Details
-
14.2.2 ProteoTech, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 ProteoTech, Inc Amyloidosis Therapeutics Product and Service
-
14.3 Celgene Corporation
-
14.3.1 Celgene Corporation Company Details
-
14.3.2 Celgene Corporation Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Corporation Amyloidosis Therapeutics Product and Service
-
14.4 Onyx Pharmaceuticals, Inc
-
14.4.1 Onyx Pharmaceuticals, Inc Company Details
-
14.4.2 Onyx Pharmaceuticals, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Onyx Pharmaceuticals, Inc Amyloidosis Therapeutics Product and Service
-
14.5 Alnylam Pharmaceuticals, Inc
-
14.5.1 Alnylam Pharmaceuticals, Inc Company Details
-
14.5.2 Alnylam Pharmaceuticals, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Alnylam Pharmaceuticals, Inc Amyloidosis Therapeutics Product and Service
-
14.6 GlaxoSmithKline Plc
-
14.6.1 GlaxoSmithKline Plc Company Details
-
14.6.2 GlaxoSmithKline Plc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline Plc Amyloidosis Therapeutics Product and Service
-
14.7 Pfizer Inc
-
14.7.1 Pfizer Inc Company Details
-
14.7.2 Pfizer Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Inc Amyloidosis Therapeutics Product and Service
-
14.8 Arcturus Therapeutics, Inc
-
14.8.1 Arcturus Therapeutics, Inc Company Details
-
14.8.2 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product and Service
-
14.9 Bsim2
-
14.9.1 Bsim2 Company Details
-
14.9.2 Bsim2 Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bsim2 Amyloidosis Therapeutics Product and Service
-
14.10 Bellus Health Inc
-
14.10.1 Bellus Health Inc Company Details
-
14.10.2 Bellus Health Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bellus Health Inc Amyloidosis Therapeutics Product and Service
-
14.11 Prothena Corporation Plc
-
14.11.1 Prothena Corporation Plc Company Details
-
14.11.2 Prothena Corporation Plc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Prothena Corporation Plc Amyloidosis Therapeutics Product and Service
-
14.12 SOM Innovation Biotech SL
-
14.12.1 SOM Innovation Biotech SL Company Details
-
14.12.2 SOM Innovation Biotech SL Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 SOM Innovation Biotech SL Amyloidosis Therapeutics Product and Service
-
14.13 Millennium Pharmaceuticals, Inc
-
14.13.1 Millennium Pharmaceuticals, Inc Company Details
-
14.13.2 Millennium Pharmaceuticals, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Millennium Pharmaceuticals, Inc Amyloidosis Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Amyloidosis Therapeutics
-
Figure Amyloidosis Therapeutics Picture
-
Table Global Amyloidosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Amyloidosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Amyloidosis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Amyloidosis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Amyloidosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Amyloidosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Amyloidosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Amyloidosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Amyloidosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Amyloidosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Amyloidosis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Amyloidosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Amyloidosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Amyloidosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Amyloidosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Amyloidosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Amyloidosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AG-10 Consumption and Growth Rate (2017-2022)
-
Figure Global ALN-ANG Consumption and Growth Rate (2017-2022)
-
Figure Global ALN-TTRsc02 Consumption and Growth Rate (2017-2022)
-
Figure Global CAEL-101 Consumption and Growth Rate (2017-2022)
-
Figure Global canakinumab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AL amyloidosis Consumption and Growth Rate (2017-2022)
-
Figure Global AA amyloidoses Consumption and Growth Rate (2017-2022)
-
Figure Global ATTR amyloidoses Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AG-10 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALN-ANG Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALN-TTRsc02 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CAEL-101 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global canakinumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AL amyloidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AA amyloidoses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ATTR amyloidoses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Amyloidosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Amyloidosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Isis Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Isis Pharmaceuticals, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Isis Pharmaceuticals, Inc Amyloidosis Therapeutics Product and Service
-
Table ProteoTech, Inc (Foundation Year, Company Profile and etc.)
-
Table ProteoTech, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProteoTech, Inc Amyloidosis Therapeutics Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Amyloidosis Therapeutics Product and Service
-
Table Onyx Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Onyx Pharmaceuticals, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Onyx Pharmaceuticals, Inc Amyloidosis Therapeutics Product and Service
-
Table Alnylam Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals, Inc Amyloidosis Therapeutics Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Amyloidosis Therapeutics Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Amyloidosis Therapeutics Product and Service
-
Table Arcturus Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product and Service
-
Table Bsim2 (Foundation Year, Company Profile and etc.)
-
Table Bsim2 Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bsim2 Amyloidosis Therapeutics Product and Service
-
Table Bellus Health Inc (Foundation Year, Company Profile and etc.)
-
Table Bellus Health Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bellus Health Inc Amyloidosis Therapeutics Product and Service
-
Table Prothena Corporation Plc (Foundation Year, Company Profile and etc.)
-
Table Prothena Corporation Plc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prothena Corporation Plc Amyloidosis Therapeutics Product and Service
-
Table SOM Innovation Biotech SL (Foundation Year, Company Profile and etc.)
-
Table SOM Innovation Biotech SL Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table SOM Innovation Biotech SL Amyloidosis Therapeutics Product and Service
-
Table Millennium Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Millennium Pharmaceuticals, Inc Amyloidosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Millennium Pharmaceuticals, Inc Amyloidosis Therapeutics Product and Service
-
